Vivos (RDGL) Cash from Operations Growth (1y) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -7.20% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 132.40% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -35.67% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -84.38% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 122.43% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 185.96% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 16.00% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.60% |
| 10 | Vivos | - | - | -3,105.00 | -14.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -14.58% |
| Sep 30, 2025 | 9.44% |
| Jun 30, 2025 | -70.09% |
| Mar 31, 2025 | -29.52% |
| Dec 31, 2024 | -1.68% |
| Sep 30, 2024 | -128.12% |
| Jun 30, 2024 | -13.07% |
| Mar 31, 2024 | -19.70% |
| Dec 31, 2023 | -64.43% |
| Sep 30, 2023 | 21.57% |
| Jun 30, 2023 | -83.70% |
| Mar 31, 2023 | 23.59% |
| Dec 31, 2022 | -19.62% |
| Sep 30, 2022 | -58.90% |
| Jun 30, 2022 | 50.71% |
| Mar 31, 2022 | -89.22% |
| Dec 31, 2021 | 35.59% |
| Sep 30, 2021 | 3.18% |
| Jun 30, 2021 | -45.23% |
| Mar 31, 2021 | -132.78% |
| Dec 31, 2020 | -44.41% |
| Sep 30, 2020 | 0.56% |
| Jun 30, 2020 | -87.81% |
| Mar 31, 2020 | 67.89% |
| Dec 31, 2019 | 52.47% |
| Sep 30, 2019 | -160.76% |
| Jun 30, 2019 | -162.04% |
| Mar 31, 2019 | -462.52% |
| Dec 31, 2018 | -225.19% |
| Sep 30, 2018 | 79.58% |
| Jun 30, 2018 | 90.31% |
| Mar 31, 2018 | 82.48% |
| Dec 31, 2017 | 95.42% |
| Sep 30, 2017 | -111.09% |
| Jun 30, 2017 | 45.08% |
| Mar 31, 2017 | 51.88% |
| Dec 31, 2016 | -591.98% |
| Sep 30, 2016 | 2,475.28% |
| Jun 30, 2016 | -223.96% |
| Mar 31, 2016 | -117.62% |
| Dec 31, 2015 | -49.62% |
| Sep 30, 2015 | -336.16% |
| Jun 30, 2015 | 15.37% |
| Mar 31, 2015 | 38.45% |
| Dec 31, 2014 | -100.74% |
| Sep 30, 2014 | 91.81% |
| Jun 30, 2014 | 65.11% |
| Mar 31, 2014 | 20.96% |
| Dec 31, 2013 | 51.06% |
| Sep 30, 2013 | 43.39% |
| Jun 30, 2013 | -85.06% |
| Mar 31, 2013 | -93.11% |
| Dec 31, 2012 | -24.93% |
| Sep 30, 2012 | -200.64% |
| Jun 30, 2012 | -141.54% |
| Mar 31, 2012 | -90.24% |
| Dec 31, 2011 | 82.75% |
| Sep 30, 2011 | 32.58% |